| Product Code: ETC9970023 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Medical Imaging Agents Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Medical Imaging Agents Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Medical Imaging Agents Market - Industry Life Cycle |
3.4 United States (US) Medical Imaging Agents Market - Porter's Five Forces |
3.5 United States (US) Medical Imaging Agents Market Revenues & Volume Share, By Isotope, 2021 & 2031F |
3.6 United States (US) Medical Imaging Agents Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.7 United States (US) Medical Imaging Agents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) Medical Imaging Agents Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 United States (US) Medical Imaging Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Technological advancements leading to the development of innovative medical imaging agents |
4.2.2 Increasing prevalence of chronic diseases and the need for accurate diagnosis and monitoring |
4.2.3 Growing investments in healthcare infrastructure and facilities |
4.3 Market Restraints |
4.3.1 High cost associated with medical imaging agents |
4.3.2 Stringent regulatory requirements and approval processes for new imaging agents |
5 United States (US) Medical Imaging Agents Market Trends |
6 United States (US) Medical Imaging Agents Market, By Types |
6.1 United States (US) Medical Imaging Agents Market, By Isotope |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Medical Imaging Agents Market Revenues & Volume, By Isotope, 2021- 2031F |
6.1.3 United States (US) Medical Imaging Agents Market Revenues & Volume, By Technetium, 2021- 2031F |
6.1.4 United States (US) Medical Imaging Agents Market Revenues & Volume, By Thallium, 2021- 2031F |
6.1.5 United States (US) Medical Imaging Agents Market Revenues & Volume, By Gallium, 2021- 2031F |
6.1.6 United States (US) Medical Imaging Agents Market Revenues & Volume, By Iodine, 2021- 2031F |
6.1.7 United States (US) Medical Imaging Agents Market Revenues & Volume, By Samarium, 2021- 2031F |
6.1.8 United States (US) Medical Imaging Agents Market Revenues & Volume, By Rhenium, 2021- 2031F |
6.1.9 United States (US) Medical Imaging Agents Market Revenues & Volume, By Gallium, 2021- 2031F |
6.1.10 United States (US) Medical Imaging Agents Market Revenues & Volume, By Gallium, 2021- 2031F |
6.2 United States (US) Medical Imaging Agents Market, By Modality |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Medical Imaging Agents Market Revenues & Volume, By X-Ray/CT, 2021- 2031F |
6.2.3 United States (US) Medical Imaging Agents Market Revenues & Volume, By MRI, 2021- 2031F |
6.2.4 United States (US) Medical Imaging Agents Market Revenues & Volume, By Ultrasound, 2021- 2031F |
6.2.5 United States (US) Medical Imaging Agents Market Revenues & Volume, By SPECT, 2021- 2031F |
6.2.6 United States (US) Medical Imaging Agents Market Revenues & Volume, By PET, 2021- 2031F |
6.3 United States (US) Medical Imaging Agents Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Medical Imaging Agents Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.3.3 United States (US) Medical Imaging Agents Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 United States (US) Medical Imaging Agents Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.3.5 United States (US) Medical Imaging Agents Market Revenues & Volume, By Musculoskeletal, 2021- 2031F |
6.3.6 United States (US) Medical Imaging Agents Market Revenues & Volume, By Neurology, 2021- 2031F |
6.3.7 United States (US) Medical Imaging Agents Market Revenues & Volume, By Nephrology, 2021- 2031F |
6.3.8 United States (US) Medical Imaging Agents Market Revenues & Volume, By Pulmonary, 2021- 2031F |
6.3.9 United States (US) Medical Imaging Agents Market Revenues & Volume, By Pulmonary, 2021- 2031F |
6.4 United States (US) Medical Imaging Agents Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Medical Imaging Agents Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.4.3 United States (US) Medical Imaging Agents Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.4 United States (US) Medical Imaging Agents Market Revenues & Volume, By Academic Institutes and Research Organizations, 2021- 2031F |
7 United States (US) Medical Imaging Agents Market Import-Export Trade Statistics |
7.1 United States (US) Medical Imaging Agents Market Export to Major Countries |
7.2 United States (US) Medical Imaging Agents Market Imports from Major Countries |
8 United States (US) Medical Imaging Agents Market Key Performance Indicators |
8.1 Adoption rate of new medical imaging agents by healthcare facilities |
8.2 Number of research studies and clinical trials involving medical imaging agents |
8.3 Rate of growth in usage of medical imaging agents in different medical specialties |
8.4 Patient outcomes and diagnostic accuracy improvement attributed to medical imaging agents |
9 United States (US) Medical Imaging Agents Market - Opportunity Assessment |
9.1 United States (US) Medical Imaging Agents Market Opportunity Assessment, By Isotope, 2021 & 2031F |
9.2 United States (US) Medical Imaging Agents Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.3 United States (US) Medical Imaging Agents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) Medical Imaging Agents Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 United States (US) Medical Imaging Agents Market - Competitive Landscape |
10.1 United States (US) Medical Imaging Agents Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Medical Imaging Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here